Latest filing published 20 Nov 2024 for Ironwood Pharmaceuticals INC, €21k.
Filing timeline
BuySaleInsider track record
Andrew Davis: trading record in brief
Andrew Davis is a declared insider of Ironwood Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 11 filings; the first trade dates from 21 November 2022 and the latest from 18 November 2024.
The open-market record consists of 8 sales worth €459k, with no purchase. Other entries cover 2 share grants and 1 option exercise. 2024 to date brings no purchases and 3 sales.
The latest filing, published on 20 November 2024, reports an open-market sale of €21k in Ironwood Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,360 shares@ US$4.084.7% of flowClass A Common StockSEC:0000950170-24-129228:0
- 22,725 shares@ US$6.4530.7% of flowClass A Common StockSEC:0000950170-24-063482:0
- 37,120 shares0Class A Common StockSEC:0000950170-24-029910:0
- 9,846 shares@ US$15.2431.6% of flowClass A Common StockSEC:0000950170-24-015548:0
- 3,287 shares@ US$9.696.6% of flowClass A Common StockSEC:0001209191-23-056446:0
- 6,305 shares@ US$10.1213.4% of flowClass A Common StockSEC:0001209191-23-031873:0
- 74,236 shares0Class A Common StockSEC:0001209191-23-017873:0
- 1,751 shares@ US$11.414.3% of flowClass A Common StockSEC:0001209191-23-014276:0
- 3,335 shares@ US$11.568.5% of flowClass A Common StockSEC:0001209191-22-058607:0
9 of 9 declarations
